Table 5.
Prevalence Ratios for Cardiovascular Risk Factors, by Disease
| Model 1: Unadjusted | Model 2: Adjusted for Age, Sex | Model 3: Model 2+Race | Model 4: Model 3+Enrollment eGFR | |
|---|---|---|---|---|
| Hypertension or hypertensive‐level blood pressurea | ||||
| MCD | 1.4 (1.1–1.8) | 1.3 (1.0–1.7) | 1.2 (1.0–1.6) | 1.3 (1.0–1.7) |
| FSGS | 1.5 (1.1–1.9) | 1.5 (1.1–1.9) | 1.3 (1.0–1.7) | 1.3 (1.0–1.8) |
| MN | 2.0 (1.4–2.8) | 2.1 (1.4–3.0) | 1.9 (1.3–2.8) | 1.9 (1.3–2.8) |
| IgAN/IgAV | Ref. | Ref. | Ref. | Ref. |
| Hypercholesterolemia | ||||
| MCD | 1.8 (1.3–2.4) | 1.7 (1.2–2.2) | 1.6 (1.2–2.1) | 1.6 (1.2–2.1) |
| FSGS | 1.5 (1.1–2.0) | 1.4 (1.0–1.9) | 1.3 (1.0–1.8) | 1.4 (1.0–1.9) |
| MN | 2.0 (1.5–2.9) | 2.1 (1.5–2.9) | 2.1 (1.5–2.9) | 2.1 (1.5–2.9) |
| IgAN/IgAV | Ref. | Ref. | Ref. | Ref. |
| Obesity | ||||
| MCD | 1.1 (0.8–1.4) | 1.0 (0.8–1.3) | 1.0 (0.7–1.3) | 0.9 (0.7–1.3) |
| FSGS | 1.3 (1.0–1.7) | 1.3 (1.0–1.7) | 1.2 (0.9–1.6) | 1.1 (0.8–1.5) |
| MN | 1.5 (1.0–2.3) | 1.6 (1.0–2.4) | 1.5 (1.0–2.4) | 1.4 (0.9–2.2) |
| IgAN/IgAV | Ref. | Ref. | Ref. | Ref. |
eGFR indicates estimated glomerular filtration rate; FSGS, focal segmental glomerulosclerosis; IgAN, IgA nephropathy; IgAV, IgA vasculitis; MCD, minimal change disease; MN, membranous nephropathy; ref, reference.
a
Self‐reported history or enrollment systolic and/or diastolic blood pressure >95th percentile.